The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of at...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/9/22870 |
id |
doaj-11c3e85c34914cfca9c9b2c33d68a6ce |
---|---|
record_format |
Article |
spelling |
doaj-11c3e85c34914cfca9c9b2c33d68a6ce2020-11-24T22:22:24ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-09-01169228702288710.3390/ijms160922870ijms160922870The Current Role of Omega-3 Fatty Acids in the Management of Atrial FibrillationGeorgios A. Christou0Konstantinos A. Christou1Panagiotis Korantzopoulos2Evangelos C. Rizos3Dimitrios N. Nikas4John A. Goudevenos5Laboratory of Physiology, Medical School, University of Ioannina, 45110 Ioannina, GreeceFirst Department of Internal Medicine, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceSecond Medical Department and Outpatient Lipid Clinic, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceFirst Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, GreeceBackground: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of atrial fibrillation (AF) and the possible underlying mechanisms. Methods: A literature search based on PubMed listings was performed using “Omega-3 fatty acids” and “atrial fibrilation” as key search terms. Results: n-3 PUFA have been shown to attenuate structural atrial remodeling, prolong atrial effective refractory period through the prevention of reentry and suppress ectopic firing from pulmonary veins. Dietary fish intake has been found to have no effect on the incidence of AF in the majority of studies. Circulating DHA has been consistently reported to be inversely associated with AF risk, whereas EPA has no such effect. The majority of studies investigating the impact of n-3 PUFA supplementation on the incidence of AF following cardiac surgery reported no benefit, though most of them did not use n-3 PUFA pretreatment for adequate duration. Studies using adequate four-week pretreatment with n-3 PUFA before cardioversion of AF showed a reduction of the AF incidence. Conclusions: Although n-3 PUFA have antiarrhythmogenic properties, their clinical efficacy on the prevention of AF is not consistently supported. Further well-designed studies are needed to overcome the limitations of the existing studies and provide robust conclusions.http://www.mdpi.com/1422-0067/16/9/22870omega-3 fatty acidseicosapentaenoic aciddocosahexaenoic acidfish oilatrial fibrillationcardiac surgerycardioversionarrhythmia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Georgios A. Christou Konstantinos A. Christou Panagiotis Korantzopoulos Evangelos C. Rizos Dimitrios N. Nikas John A. Goudevenos |
spellingShingle |
Georgios A. Christou Konstantinos A. Christou Panagiotis Korantzopoulos Evangelos C. Rizos Dimitrios N. Nikas John A. Goudevenos The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation International Journal of Molecular Sciences omega-3 fatty acids eicosapentaenoic acid docosahexaenoic acid fish oil atrial fibrillation cardiac surgery cardioversion arrhythmia |
author_facet |
Georgios A. Christou Konstantinos A. Christou Panagiotis Korantzopoulos Evangelos C. Rizos Dimitrios N. Nikas John A. Goudevenos |
author_sort |
Georgios A. Christou |
title |
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
title_short |
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
title_full |
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
title_fullStr |
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
title_full_unstemmed |
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
title_sort |
current role of omega-3 fatty acids in the management of atrial fibrillation |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2015-09-01 |
description |
Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the present manuscript, we aimed to review the current evidence regarding the clinical role of n-3 PUFA in the prevention of atrial fibrillation (AF) and the possible underlying mechanisms. Methods: A literature search based on PubMed listings was performed using “Omega-3 fatty acids” and “atrial fibrilation” as key search terms. Results: n-3 PUFA have been shown to attenuate structural atrial remodeling, prolong atrial effective refractory period through the prevention of reentry and suppress ectopic firing from pulmonary veins. Dietary fish intake has been found to have no effect on the incidence of AF in the majority of studies. Circulating DHA has been consistently reported to be inversely associated with AF risk, whereas EPA has no such effect. The majority of studies investigating the impact of n-3 PUFA supplementation on the incidence of AF following cardiac surgery reported no benefit, though most of them did not use n-3 PUFA pretreatment for adequate duration. Studies using adequate four-week pretreatment with n-3 PUFA before cardioversion of AF showed a reduction of the AF incidence. Conclusions: Although n-3 PUFA have antiarrhythmogenic properties, their clinical efficacy on the prevention of AF is not consistently supported. Further well-designed studies are needed to overcome the limitations of the existing studies and provide robust conclusions. |
topic |
omega-3 fatty acids eicosapentaenoic acid docosahexaenoic acid fish oil atrial fibrillation cardiac surgery cardioversion arrhythmia |
url |
http://www.mdpi.com/1422-0067/16/9/22870 |
work_keys_str_mv |
AT georgiosachristou thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT konstantinosachristou thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT panagiotiskorantzopoulos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT evangeloscrizos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT dimitriosnnikas thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT johnagoudevenos thecurrentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT georgiosachristou currentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT konstantinosachristou currentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT panagiotiskorantzopoulos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT evangeloscrizos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT dimitriosnnikas currentroleofomega3fattyacidsinthemanagementofatrialfibrillation AT johnagoudevenos currentroleofomega3fattyacidsinthemanagementofatrialfibrillation |
_version_ |
1725768567147724800 |